ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d

January 10, 1992

Cancer Incidence Rates Climb In HIV-Positive Female Populations

April 27, 2012

ACCC Members Find Few Answers, Many Problems

February 7, 1975

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

HHS Awards $85 Million For Research to Eliminate Health Disparities

November 15, 2002

Modeling: Like The Sims But No Graphics

November 26, 2010